Cargando…

Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases? †

Biphalin, one of the opioid agonists, is a dimeric analog of enkephalin with a high affinity for opioid receptors. Opioid receptors are widespread in the central nervous system and in peripheral neuronal and non-neuronal tissues. Hence, these receptors and their agonists, which play an important rol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Redkiewicz, Patrycja, Dyniewicz, Jolanta, Misicka, Aleksandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582929/ https://www.ncbi.nlm.nih.gov/pubmed/34768778 http://dx.doi.org/10.3390/ijms222111347

Ejemplares similares

Brain Delivery of a Potent Opioid Receptor Agonist, Biphalin during Ischemic Stroke: Role of Organic Anion Transporting Polypeptide (OATP)
por: Albekairi, Thamer H, et al.
Publicado: (2019)

Antinociceptive and Cytotoxic Activity of Opioid Peptides with Hydrazone and Hydrazide Moieties at the C-Terminus
por: Dyniewicz, Jolanta, et al.
Publicado: (2020)

Gα(i)-derived peptide binds the µ-opioid receptor
por: Kossoń, Piotr, et al.
Publicado: (2023)

Neuroprotective Potential of Biphalin, Multireceptor Opioid Peptide, Against Excitotoxic Injury in Hippocampal Organotypic Culture
por: Kawalec, Maria, et al.
Publicado: (2011)

Biphalin, a Dimeric Enkephalin, Alleviates LPS-Induced Activation in Rat Primary Microglial Cultures in Opioid Receptor-Dependent and Receptor-Independent Manners
por: Popiolek-Barczyk, Katarzyna, et al.
Publicado: (2017)

In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
por: Guillemyn, Karel, et al.
Publicado: (2012)

Discovery of Kynurenines Containing Oligopeptides as Potent Opioid Receptor Agonists
por: Szűcs, Edina, et al.
Publicado: (2020)

Bifunctional Opioid/Melanocortin Peptidomimetics for Use in Neuropathic Pain: Variation in the Type and Length of the Linker Connecting the Two Pharmacophores
por: Witkowska, Ewa, et al.
Publicado: (2022)

In Vivo, In Vitro and In Silico Studies of the Hybrid Compound AA3266, an Opioid Agonist/NK1R Antagonist with Selective Cytotoxicity
por: Matalińska, Joanna, et al.
Publicado: (2020)

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
por: Day, Nathaniel, et al.
Publicado: (2022)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study
por: von Bernuth, Kira, et al.
Publicado: (2020)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
por: Soyka, Michael
Publicado: (2021)

Interim opioid agonist treatment for opioid addiction: a systematic review
por: Samsó Jofra, Laura, et al.
Publicado: (2022)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Rescue Analgesia for Opioid-Dependent Individuals on Opioid Agonist Treatment during Hospitalization: Adherence to Guideline Treatment
por: Arnet, Isabelle, et al.
Publicado: (2023)

β(2)-Homo-Amino Acid Scan of µ-Selective Opioid Tetrapeptide TAPP
por: Tymecka, Dagmara, et al.
Publicado: (2020)

State-dependent inhibition of BK channels by the opioid agonist loperamide
por: Vouga, Alexandre G., et al.
Publicado: (2021)

A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence
por: Chetty, Mersha, et al.
Publicado: (2017)

Novel bifunctional hybrid compounds designed to enhance the effects of opioids and antagonize the pronociceptive effects of nonopioid peptides as potent analgesics in a rat model of neuropathic pain
por: Piotrowska, Anna, et al.
Publicado: (2021)

The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study
por: Gisev, Natasa, et al.
Publicado: (2019)

Discovery of SHR9352: A Highly Potent G Protein-Biased μ-Opioid Receptor Agonist
por: Li, Xin, et al.
Publicado: (2017)

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
por: Shen, Qianwei, et al.
Publicado: (2017)

Alcohol use in opioid agonist treatment
por: Nolan, Seonaid, et al.
Publicado: (2016)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

The Panacea
Publicado: (1860)

The Panacea
Publicado: (1876)

Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence
por: Mistry, Chetna J, et al.
Publicado: (2014)

Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India
por: Bhat, Fazle R., et al.
Publicado: (2022)

What is the benefit of inconsistent opioid agonist treatment in patients with prescription opioid use disorder?
por: Weiss, R., et al.
Publicado: (2023)

Scandium-44 Radiolabeled Peptide and Peptidomimetic Conjugates Targeting Neuropilin-1 Co-Receptor as Potential Tools for Cancer Diagnosis and Anti-Angiogenic Therapy
por: Masłowska, Katarzyna, et al.
Publicado: (2023)

Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment
por: Marchand, Kirsten, et al.
Publicado: (2012)

Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance
por: Gibula-Tarlowska, Ewa, et al.
Publicado: (2020)

Availability of opioid agonist treatment and critical incidents in Forensic Clinics for Dependency Diseases in Germany
por: Reiners, Sven, et al.
Publicado: (2022)

Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis
por: Jones, Deuan C., et al.
Publicado: (2010)

Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor
por: Ben Haddou, Tanila, et al.
Publicado: (2014)

Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists
por: Dumitrascuta, Maria, et al.
Publicado: (2017)

Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis
por: Lipiński, Piotr F. J., et al.
Publicado: (2019)

Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden
por: Panchal, S J, et al.
Publicado: (2007)

Opioid-Induced Constipation: Pathophysiology, Clinical Consequences, and Management
por: Kumar, Lalit, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ammqq4l7rtf0ifcqalvdsaq6s9